Myomo to Conduct Safe Patient Screenings.

INTERNET BUSINESS NEWS-(C)1995-2020 M2 COMMUNICATIONS

Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, has reported the success of its initiative to conduct safe patient screenings remotely using telehealth technologies, the company said.

Myomo's field clinicians are now doing nearly 100 remote screenings per month. In May, 92% of the candidates evaluated via this process were medically qualified for a MyoPro, and these patients then move into our reimbursement pipeline for an insurance authorization. Over 500...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT